What Are the Predictive Factors for Preeclampsia in Oocyte Recipients? - PREROVE

The main goal is to determine which risk factors develop preeclampsia in this specific group of oocyte recipients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pregnancy Oocyte Donation

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

CHU de Rennes, Rennes, France

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All major patients with a pregnancy of more than 22 weeks of amenorrhea resulting from an oocyte donation in one of the study centers, having given birth between January 2010 and April 2017 and not opposed to participation in the study.

Exclusion criteria

all pregnancies resulting from an oocyte donation abroad, persons of legal age subject to legal protection (safeguard of justice, guardianship, tutorship) and persons deprived of their liberty.

Treatment and study plan

preeclampsia

Other

occurrence of pre-eclampsia

Primary outcomes

occurrence of pre-eclampsia

Time frame: through study completion, an average of 1 year

Sponsors and collaborators

Lead sponsor

Rennes University Hospital

Other

Registry information

Acronym: PREROVE

Important dates

Study start: 2018
Primary completion: 2018
Study completion: 2018
First posted: Sep 12, 2018
Registry last updated: Apr 12, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed